Key Highlights

  • SSNC is trading up 0.25% at $87.14 on October 21, with a market capitalization of about $20.45 billion.
  • Third-quarter results are due after the close on Thursday, October 22, with a call at 5:00 p.m. ET.
  • Second-quarter revenue was $1.696 billion, up 10.3%, with adjusted EPS of $1.76, up 18.1%.
  • Third-quarter guidance is for revenue of $1.657 billion to $1.697 billion and adjusted EPS of $1.73 to $1.79.
  • Trailing EPS is $3.48, the P/E is 25.02 and the dividend yield is 1.28%.

What Does the Market Need to See From SS&C's Organic Growth and Margins on October 22?

SS&C Technologies (NASDAQ:SSNC) is trading up 0.25% at $87.14 on October 21, with no company-specific news for the session. The company reports third-quarter results after the close on Thursday, October 22, with a call at 5:00 p.m. ET.

SS&C provides software and outsourced services to clients in financial services and health care, including fund administration, the Black Diamond wealth platform and the Intralinks deal-room business. Its market capitalization is about $20.45 billion.

What investors are waiting for is organic growth that holds up after a second quarter lifted by large license renewals, steady margins and reassurance on AI-driven disruption.

What Did the Second-Quarter Call Set Up for the Third Quarter?

Second-quarter revenue was $1.696 billion, up 10.3%, with organic growth of 7.6%. Management said large license renewals added a couple of hundred basis points to organic growth and that renewal timing makes results uneven. Adjusted EPS was $1.76, up 18.1%, and GAAP EPS was $0.97. Adjusted EBITDA was $671 million at a 39.5% margin, up 50 basis points.

The company repurchased 6.4 million shares for $435.2 million, its largest quarterly buyback, cutting the diluted share count to 242 million from 252.2 million a year earlier. Net debt was $7.2 billion, a net leverage of 2.75x, and management is exploring a refinancing of bonds maturing in 2027.

Third-quarter guidance is for revenue of $1.657 billion to $1.697 billion, about 5% organic growth at the midpoint, and adjusted EPS of $1.73 to $1.79. The midpoint implies revenue about 7.0% above the year-ago $1.568 billion, calculated. Full-year guidance was raised to revenue of $6.672 billion to $6.832 billion and adjusted EPS of $6.93 to $7.25, with a margin goal of 40% in the fourth quarter.

Which Readings Would Be Encouraging or Concerning?

Encouraging readings would be revenue inside or above the guided range, an adjusted EBITDA margin near 40% and continued progress at the recently acquired Calastone, which management said is ahead of plan. Another point is the health care business, where a six-month government-backed GLP-1 bridge program has processed nearly 3 million claims since its July 1 launch. Management described the odds of its continuation as roughly even.

Concerning readings would be organic growth slipping well below the roughly 5% implied for the quarter, margin compression, a cautious full-year range or competitive pressure in outsourcing wins. Commentary on AI is a further lens, since management cited it as a driver of growth and margin expansion while investors weigh disruption risk for software.

These are the items investors will look for and not predictions.

How Do Trailing Figures Frame the Report?

Trailing EPS is $3.48, up 9.70%, on a GAAP basis that differs from adjusted earnings. The P/E is 25.02, the dividend yield is 1.28% and the consensus analyst rating is Buy. The year-ago third quarter produced GAAP EPS of $0.83.

After October 22, investors will watch whether management reaffirms its growth trajectory, how acquisitions contribute and what it says about AI exposure across fund administration and wealth management.